Eagle Ridge Investment Management Novartis Ag Transaction History

Eagle Ridge Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 29, 2020	SELL	$70.67 - $99.01 $158,795 - $222,475	-2,247 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$84.35 - $95.37 $189,534 - $214,296	2,247 New	2,247 $213,000
Q3 2019 Oct 31, 2019	SELL	$85.54 - $94.26 $230,615 - $254,124	-2,696 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$75.4 - $92.8 $33,930 - $41,760	-450 Reduced 14.3%	2,696 $246,000
Q4 2018 Feb 07, 2019	SELL	$73.66 - $82.02 $18,415 - $20,505	-250 Reduced 7.36%	3,146 $270,000
Q3 2018 Nov 09, 2018	SELL	$66.94 - $77.43 $33,470 - $38,715	-500 Reduced 12.83%	3,396 $293,000
Q2 2018 Jul 26, 2018	SELL	$64.91 - $73.36 $97,365 - $110,040	-1,500 Reduced 27.8%	3,896 $294,000
Q1 2018 Apr 25, 2018	SELL	$70.39 - $84.15 $21,117 - $25,245	-300 Reduced 5.27%	5,396 $436,000
Q3 2017 Oct 26, 2017	BUY	$74.14 - $77.27 $422,301 - $440,129	5,696	5,696 $489,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Eagle Ridge Investment Management, based on Form 13F filings with the SEC.

Stay updated on Eagle Ridge Investment Management with notifications on news.